{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:29:44Z","timestamp":1787851784101,"version":"build-2784847793"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2025.144059","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}}],"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijbiomac.2025.144059","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:12:40Z","timestamp":1746724360000},"page":"144059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["RETRACTED: Proteomic hub proteins CDKN2B, TRAPPC2L, WFS1, and ARPP19 drive biochemical recurrence and metastatic progression in prostate cancer: Protein macromolecule action"],"prefix":"10.1016","volume":"311","author":[{"given":"Junkai","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ijbiomac.2025.144059_bb0005","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144059_bb0010","first-page":"88","article-title":"Diagnostic accuracy of (18)F-PSMA-1007 PET\/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2022","journal-title":"Hell. J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144059_bb0015","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1080\/08941939.2022.2101165","article-title":"Is PSA still the best predictor for biochemical recurrence after radical prostatectomy in high-risk prostate cancer?","volume":"35","author":"Akan","year":"2022","journal-title":"J. Investig. Surg."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144059_bb0020","doi-asserted-by":"crossref","DOI":"10.1148\/rg.230112","article-title":"MRI and PSMA PET\/CT of biochemical recurrence of prostate cancer","volume":"43","author":"Awiwi","year":"2023","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144059_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.918419","article-title":"Heparanase regulates EMT and cancer stem cell properties in prostate tumors","volume":"12","author":"Masola","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144059_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13238-020-00786-8","article-title":"Pioneer of prostate cancer: past, present and the future of FOXA1","volume":"12","author":"Teng","year":"2021","journal-title":"Protein Cell"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144059_bb0040","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3390\/cancers14081894","article-title":"Histone demethylase KDM5C drives prostate cancer progression by promoting EMT","volume":"14","author":"Lemster","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144059_bb0045","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1172\/JCI126327","article-title":"Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1","volume":"130","author":"Wang","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144059_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","article-title":"Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis","volume":"16","author":"Ye","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129369","article-title":"A FOXC2 inhibitor, MC-1-F2, as a therapeutic candidate for targeting EMT in castration-resistant prostate cancer","volume":"91","author":"Castaneda","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144059_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/md21060345","article-title":"Holothurin a inhibits RUNX1-enhanced EMT in metastasis prostate cancer via the Akt\/JNK and P38 MAPK signaling pathway","volume":"21","author":"Janta","year":"2023","journal-title":"Mar. Drugs"},{"issue":"840","key":"10.1016\/j.ijbiomac.2025.144059_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adc9142","article-title":"MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT","volume":"17","author":"Liu","year":"2024","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144059_bb0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41418-024-01295-5","article-title":"Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144059_bb0075","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00432-021-03618-2","article-title":"Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT","volume":"147","author":"Zhao","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144059_bb0080","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41419-024-07142-2","article-title":"KIF1A promotes neuroendocrine differentiation in prostate cancer by regulating the OGT-mediated O-GlcNAcylation","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112180","article-title":"TGFBI: a novel therapeutic target for cancer","volume":"134","author":"Huang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.144059_bb0090","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.3390\/ijms222312840","article-title":"Reduced Zeb1 expression in prostate cancer cells leads to an aggressive partial-EMT phenotype associated with altered global methylation patterns","volume":"22","author":"Kitz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120031","article-title":"EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways","volume":"286","author":"Rajput","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144059_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/genes13010135","article-title":"Expression of fibroblast activation protein is enriched in neuroendocrine prostate cancer and predicts worse survival","volume":"13","author":"Vlachostergios","year":"2022","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144059_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41420-021-00764-x","article-title":"Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT","volume":"7","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105689","article-title":"Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1","volume":"201","author":"Kotolloshi","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.144059_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70264","article-title":"Associations of the expression levels and risk variants of CDKN2B-AS1 long noncoding RNA with the susceptibility and progression of prostate cancer","volume":"28","author":"Tung","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0120","article-title":"Integrative epigenome map of the normal human prostate provides insights into prostate cancer predisposition","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144059_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/16078454.2021.1872275","article-title":"Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma","volume":"26","author":"Yin","year":"2021","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144059_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002944","article-title":"Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment","volume":"10","author":"Tong","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.523962","article-title":"Moringa oleifera alkaloids inhibited PC3 cells growth and migration through the COX-2 mediated Wnt\/\u03b2-catenin signaling pathway","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.144059_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.760933","article-title":"Corrigendum: Moringa oleifera alkaloids inhibited PC3 cells growth and migration through the COX-2 mediated Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2025.144059","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}},{"DOI":"10.1016\/j.ijbiomac.2026.153468","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000}},{"DOI":"10.1016\/j.ijbiomac.2026.153468","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"record-id":"72436"},{"DOI":"10.1016\/j.ijbiomac.2026.153468","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025046112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025046112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:23:43Z","timestamp":1782883423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025046112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"alternative-id":["S0141813025046112"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144059","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Proteomic hub proteins CDKN2B, TRAPPC2L, WFS1, and ARPP19 drive biochemical recurrence and metastatic progression in prostate cancer: Protein macromolecule action","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144059"}}